Motive Health Celebrates First Year as DTC Brand

Motive Health, Inc., the innovative healthcare technology company behind the first FDA-cleared neuromuscular electrical stimulation device for knee pain, marks its first year as a direct-to-consumer (DTC) brand. The company previously offered its prescription-only products under the brand CyMedica Orthopedics, is also celebrating ten years in business, and has helped over 25,000 people combat knee issues with their patented technology to date.
 
The company sold products in all 50 states by expanding its retail presence on Amazon, building a loyal community in the first 12 months of selling DTC.
 
“Seeing the positive outcomes Motive has been able to provide for people suffering from knee pain has been a profound experience,” commented Rob Morocco, President and CEO of Motive Health. “This technology can change someone’s life. From a grandfather hoping to regain the mobility to play with his grandkids again to an avid runner finally getting back on track after an injury, bringing Motive directly to consumers has opened a whole new world of possibilities. We learned a lot in this first year and we’re excited and energized for the ways we’ll continue to grow in year two and beyond.”
 
In 2014, The brand was initially conceived by orthopedic surgeon, Dr. Struan Coleman (Hospital for Special Surgery), and Motive’s neuromuscular electrical stimulation (NMES) technology was brought to life out of a desire to provide everyday patients with treatments only professional athletes had access to. Less than a decade later, Motive achieved FDA clearance for muscle strengthening and knee pain treatment, completed rigorous clinical trials, and secured FDA clearance to begin offering the treatment without a prescription. 
 
Motive’s team of innovators is staying hard at work to identify new enhancements to the product and its corresponding app that will expand use cases and enhance the user experience. Motive is also looking to expand its retail footprint with additional e-commerce partners. While treating knee pain will always be core to the Motive brand, the company will continue to evaluate how its technology may support other areas of the body impacted by joint pain.